Purpose-Built Biobanking LIMS for Managing COVID-19 Testing
Delivered as a comprehensive Software-As-A-Service (SaaS) solution, the LabVantage COVID-19 Biobanking Accelerator requires no infrastructure investment.
Blood-Based PD-L1 Circulating Tumor Cell Assay
The PD-L1 assay and the AccuCyte-CyteFinder system processes a single tube of blood to cells for CTC enumeration and PD-L1 biomarker expression analysis, and to plasma for optional cfDNA analysis.
COVID-19 Symptom Checker for Individual Monitoring
COVID-19 Compass is based on CDC guidelines, best clinical practices, illness severity, and risk factors such as age, gender, location, potential exposure and pre-existing health conditions.
Esophageal DNA Test for Barrett’s Esophagus
EsoGuard is designed to facilitate the diagnosis of Barrett’s Esophagus (BE) and related precursors to highly lethal esophageal adenocarcinoma (EAC).
Stranded RNA Library Prep Kit
Using the kit, researchers can capture the complete transcriptome, including short (<200 bp) and long (>200 bp) RNAs, in a single library prep.
cfDNA Extraction Kits
The kit is designed for purification of circulating cfNDA and uses silica coated paramagnetic particles to purify cfDNA from less than 1 mL to greater than 10 mL of serum or plasma.
Three Liquid Biopsy Panels Target Myeloid Genes, EGFR Pathways, and TP53
Each of the new panels comes with ERASE-Seq, Fluxion's variant caller which uses statistical analysis to compare sequencing results across several molecular amplification pools.
Liquid Biopsy Test to Detect TRK Biomarkers in the Blood of Patients Diagnosed with...
Biocept's Target Selector test enables physicians to identify the potential presence of NTRK fusions used to inform on treatment options.
Genetic Report for More than 30 Cardiovascular Conditions
The new clinical report, Cardiac Care, features more than 110 genes from clinical databases spanning more than 30 different cardiovascular conditions, ranging from cardiomyopathies to rare forms of long QT syndromes.
Testing Panel for Immune Response Following Organ Transplant
NanoString Technologies has announced the launch of nCounter Human Organ Transplant, a gene expression panel for researchers to evaluate the human immune response following organ transplantation.
